These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35792649)

  • 1. Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice.
    Samsom KG; Schipper LJ; Roepman P; Bosch LJ; Lalezari F; Klompenhouwer EG; de Langen AJ; Buffart TE; Riethorst I; Schoenmaker L; Schout D; van der Noort V; van den Berg JG; de Bruijn E; van der Hoeven JJ; van Snellenberg H; van der Kolk LE; Cuppen E; Voest EE; Meijer GA; Monkhorst K
    J Pathol; 2022 Oct; 258(2):179-188. PubMed ID: 35792649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).
    Samsom KG; Bosch LJW; Schipper LJ; Roepman P; de Bruijn E; Hoes LR; Riethorst I; Schoenmaker L; van der Kolk LE; Retèl VP; Frederix GWJ; Buffart TE; van der Hoeven JJM; Voest EE; Cuppen E; Monkhorst K; Meijer GA
    BMC Med Genomics; 2020 Nov; 13(1):169. PubMed ID: 33167975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.
    Samsom KG; Bosch LJW; Schipper LJ; Schout D; Roepman P; Boelens MC; Lalezari F; Klompenhouwer EG; de Langen AJ; Buffart TE; van Linder BMH; van Deventer K; van den Burg K; Unmehopa U; Rosenberg EH; Koster R; Hogervorst FBL; van den Berg JG; Riethorst I; Schoenmaker L; van Beek D; de Bruijn E; van der Hoeven JJM; van Snellenberg H; van der Kolk LE; Cuppen E; Voest EE; Meijer GA; Monkhorst K
    Nat Protoc; 2024 Mar; 19(3):700-726. PubMed ID: 38092944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
    Robbe P; Popitsch N; Knight SJL; Antoniou P; Becq J; He M; Kanapin A; Samsonova A; Vavoulis DV; Ross MT; Kingsbury Z; Cabes M; Ramos SDC; Page S; Dreau H; Ridout K; Jones LJ; Tuff-Lacey A; Henderson S; Mason J; Buffa FM; Verrill C; Maldonado-Perez D; Roxanis I; Collantes E; Browning L; Dhar S; Damato S; Davies S; Caulfield M; Bentley DR; Taylor JC; Turnbull C; Schuh A;
    Genet Med; 2018 Oct; 20(10):1196-1205. PubMed ID: 29388947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical demands to use whole-genome sequencing in precision oncology.
    Meggendorfer M; Jobanputra V; Wrzeszczynski KO; Roepman P; de Bruijn E; Cuppen E; Buttner R; Caldas C; Grimmond S; Mullighan CG; Elemento O; Rosenquist R; Schuh A; Haferlach T
    Semin Cancer Biol; 2022 Sep; 84():16-22. PubMed ID: 34119643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
    Pruis MA; Groenendijk FH; Badloe KS; van Puffelen A; Robbrecht D; Dinjens WNM; Sleijfer S; Dingemans AC; von der Thüsen JH; Roepman P; Lolkema MP
    Br J Cancer; 2022 Sep; 127(4):776-783. PubMed ID: 35606463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
    Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
    ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.
    Schuh A; Dreau H; Knight SJL; Ridout K; Mizani T; Vavoulis D; Colling R; Antoniou P; Kvikstad EM; Pentony MM; Hamblin A; Protheroe A; Parton M; Shah KA; Orosz Z; Athanasou N; Hassan B; Flanagan AM; Ahmed A; Winter S; Harris A; Tomlinson I; Popitsch N; Church D; Taylor JC
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis.
    Hamdan A; Ewing A
    J Pathol; 2022 Jul; 257(4):479-493. PubMed ID: 35355264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome sequencing in oncology: using scenario drafting to explore future developments.
    van de Ven M; Simons MJHG; Koffijberg H; Joore MA; IJzerman MJ; Retèl VP; van Harten WH
    BMC Cancer; 2021 May; 21(1):488. PubMed ID: 33933021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
    de Schaetzen van Brienen L; Larmuseau M; Van der Eecken K; De Ryck F; Robbe P; Schuh A; Fostier J; Ost P; Marchal K
    BMC Med Genomics; 2020 Jul; 13(1):94. PubMed ID: 32631411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.
    Roepman P; de Bruijn E; van Lieshout S; Schoenmaker L; Boelens MC; Dubbink HJ; Geurts-Giele WRR; Groenendijk FH; Huibers MMH; Kranendonk MEG; Roemer MGM; Samsom KG; Steehouwer M; de Leng WWJ; Hoischen A; Ylstra B; Monkhorst K; van der Hoeven JJM; Cuppen E
    J Mol Diagn; 2021 Jul; 23(7):816-833. PubMed ID: 33964451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early technology assessment of using whole genome sequencing in personalized oncology.
    Simons M; Van De Ven M; Coupé V; Joore M; IJzerman M; Koffijberg E; Frederix G; Uyl-De Groot C; Cuppen E; Van Harten W; Retèl V
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):343-351. PubMed ID: 33910430
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study.
    Pankhurst LJ; Del Ojo Elias C; Votintseva AA; Walker TM; Cole K; Davies J; Fermont JM; Gascoyne-Binzi DM; Kohl TA; Kong C; Lemaitre N; Niemann S; Paul J; Rogers TR; Roycroft E; Smith EG; Supply P; Tang P; Wilcox MH; Wordsworth S; Wyllie D; Xu L; Crook DW;
    Lancet Respir Med; 2016 Jan; 4(1):49-58. PubMed ID: 26669893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology.
    Rossen JWA; Friedrich AW; Moran-Gilad J;
    Clin Microbiol Infect; 2018 Apr; 24(4):355-360. PubMed ID: 29117578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.
    van de Haar J; Hoes LR; Roepman P; Lolkema MP; Verheul HMW; Gelderblom H; de Langen AJ; Smit EF; Cuppen E; Wessels LFA; Voest EE
    Nat Med; 2021 Sep; 27(9):1553-1563. PubMed ID: 34373653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing based on formalin-fixed paraffin-embedded endomyocardial biopsies for genetic studies on outcomes after heart transplantation.
    Zar G; Smith JG; Smith ML; Andersson B; Nilsson J
    PLoS One; 2019; 14(6):e0217747. PubMed ID: 31166960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.
    Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefits for children with suspected cancer from routine whole-genome sequencing.
    Hodder A; Leiter SM; Kennedy J; Addy D; Ahmed M; Ajithkumar T; Allinson K; Ancliff P; Bailey S; Barnard G; Burke GAA; Burns C; Cano-Flanagan J; Chalker J; Coleman N; Cheng D; Clinch Y; Dryden C; Ghorashian S; Griffin B; Horan G; Hubank M; May P; McDerra J; Nagrecha R; Nicholson J; O'Connor D; Pavasovic V; Quaegebeur A; Rao A; Roberts T; Samarasinghe S; Stasevich I; Tadross JA; Trayers C; Trotman J; Vora A; Watkins J; Chitty LS; Bowdin S; Armstrong R; Murray MJ; Hook CE; Tarpey P; Vedi A; Bartram J; Behjati S
    Nat Med; 2024 Jul; 30(7):1905-1912. PubMed ID: 38956197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.
    van Opijnen MP; Broekman MLD; de Vos FYF; Cuppen E; van der Hoeven JJM; van Linde ME; Compter A; Beerepoot LV; van den Bent MJ; Vos MJ; Fiebrich HB; Koekkoek JAF; Hoeben A; Kho KH; Driessen CML; Jeltema HR; Robe PAJT; Maas SLN
    BMC Med Genomics; 2022 Nov; 15(1):233. PubMed ID: 36333718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.